Characterization of long-term sequelae and immune signatures in Ebola virus disease survivors from 1976-2014 in the Democratic Republic of the Congo

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 514583

Grant search

Key facts

  • Disease

    Ebola
  • start year

    2024
  • Known Financial Commitments (USD)

    $74,210.5
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Kindrachuk Kenneth J, Mbala Placide K, Rimoin Anne W
  • Research Location

    Congo (DRC)
  • Lead Research Institution

    University of Manitoba
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Post acute and long term health consequences

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Ebola virus disease (EVD) outbreaks have historically have been concentrated in Central Africa with sporadic outbreaks in the Democratic Republic of the Congo that have been increasing in frequency. In addition, Sudan virus re-emerged in Uganda following a 10 year absence. Our prior investigations in Sierra Leone have demonstrated significant mental and physical health impacts among EVD survivors 6-8 years post-recovery. However, there is little information on whether these observations are independent of geographic considerations nor whether these are conserved across Ebolavirus species. This raises important public health concerns for long-term health considerations for disease survivors. Thus, it is imperative to determine whether long-term health impacts following EVD are conserved across geographic locations and what epidemiologic or biological factors might be linked to more severe complications as well as immune durability. Here, we will address these questions with a focus on disease survivors from multiple historic EVD outbreaks within DRC. We will also examine this through questionnaires and analysis of historical samples. This investigation will address critical knowledge gaps in our understanding of this public health concern and will have important impacts for future outbreaks, including informing long-term patient care strategies.